Financial report interval: 2025.12.31 - 2026.03.31
Overview: HAOHAI BIOTEC(06826) the Revenue is 647.86 M (-2.2%);the EBIT is 84.85 M (-20.62%);the EPS is 0.363 (-13.14%).